Global Oxytocic Pharmaceuticals Market: Snapshot
Available under the brand name of
Pitocin, the drug oxytocin, which is derived from the peptide of the
same name, is commonly used on women during childbirth in order to
induce contractions. This can not only increase labor speeds and reduce
the time taken for childbirth, but can also cease bleeding after
delivery. It is almost always administered to a patient by injecting it
into their vein or muscle.
The drug, however, does not come without
side effects, the more serious among which is the excessive contraction
of the uterus after overconsumption, which could put the baby’s health
at risk. Other side effects include a reduced heart rate and nausea.
Oxytocin is also known to cause allergic reactions, including
anaphylaxis. The drug is still considered highly safe for use and is
also a part of WHO’s List of Essential Medicines.
Oxytocin may also be used as a medication
for stimulating the mother for breastfeeding. The drug can stimulate
the production of breast milk and can therefore be essential for mother
who may not be able to do so naturally.
Global Oxytocic Pharmaceuticals Market: Overview
Dubbed the “love hormone,” oxytocin is a
female reproductive hormone, produced in the hypothalamus and released
into bloodstream during childbirth. This hormone induces labor and milk
production in a lactating mother. Oxytocic drugs can be used as
uterotonic for induced labor and to reduce the chances of hemorrhage
post C-section. Besides this, oxytocic drugs are also administered in
conditions such as post-mature birth; uterine atony; pre-eclampsia,
which means hypertension during pregnancy; stillbirth; postpartum
hemorrhage; and as an adjunct therapy for treatment of autism and in
cases of incomplete abortion.
Apart from being administered to humans,
oxytocic drugs are also used as veterinary medications. Oxytocin
demonstrates its effect after delivery, during childbirth, and toward
the end stage of pregnancy.
According to the World Health
Organization, every year more than 15 million babies are born
prematurely, and this number of preterm births is expected to increase
in the coming years. As per the findings of the National Center for
Health Statistics, the U.S. alone exhibited a 23.3% labor induction rate
in 2012. Considering these statistics, the demand for oxytocic drugs is
expected increase significantly in the near future.
The report provides a comprehensive
overview of the global oxytocic pharmaceuticals market. It presents
insights into the factors influencing the market’s trajectory. The
impact of the prevailing demand and supply trends on the market
operations is also examined in the report in detail.
Global Oxytocic Pharmaceuticals Market: Key Opportunities and Threats
The increasing incidence of preterm
births and the rising rates of labor induction are the primary factors
fuelling demand from the global oxytocic pharmaceuticals market. The
rising cases of pregnancy-related complications emerging in developing
nations also translate into the increased use of oxytocic drugs.
Additionally, the market is also expected to gain from the expansion of
the health care and pharmaceutical industries in developing countries.
However, awareness regarding the side effects related to oxytocic drugs
can hamper their use to an extent, thereby restraining the global
oxytocic pharmaceuticals market.
Leading brands offer numerous oxytocic
products. Pitocin, Octocin, Evatocin, Syntocinon, Pitogin, Duratocin,
Cytotec, and Tiacinon are the most popular brands competing for a larger
share of the global oxytocic market. However, the synthetic oxytocin
derivatives segment is poised to hold the largest share in the market
owing to its easy availability. Likewise, hospitals are expected to
emerge as the major end-use sector in the market.
Global Oxytocic Pharmaceuticals Market: Region-wise Outlook
Regionally, North America has been
exhibiting the highest demand for oxytocic pharmaceuticals due to the
high prevalence of induced labor in the region. Europe is expected to
emerge as the second-largest market for oxytocic pharmaceuticals due to
the rise in oxytocin administration in response to the increasing number
of elective caesareans. The market is also anticipated to gain from the
increasing case of C-sections in countries in Asia Pacific, such as
India and China.
Global Oxytocic Pharmaceuticals Market: Vendor Landscape
To study the prevailing competitive
landscape of the market, the report profiles companies such as APP
Pharmaceuticals, LLC, LBS Labs, Baxter Healthcare Corporation, JHP
Pharmaceuticals, LLC, and Pfizer Inc. The report studies these companies
based on their business strategies, financial overview, and product
portfolio. The strengths and weaknesses of these enterprises are
analyzed. The report also presents in-depth overview of the threats and
opportunities that these companies are expected to face during the
forecast period.
The report offers a comprehensive
evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of
the market, including but not limited to: Regional markets, technology,
types, and applications.
No comments:
Post a Comment